FIELD: biochemistry.
SUBSTANCE: described is a group of inventions comprising an isolated binding molecule which specifically binds to influenza A virus and influenza virus B, recovered polynucleotide, coding said binding molecule, a vector coding said binding molecule, a host cell capable of expressing said molecule, composition for preventing or treating an influenza A infection, influenza B infection or a combination thereof in a patient, a method of producing said binding molecule, a method of preventing or treating influenza A infection, influenza B infections or a combination thereof in a patient. In one embodiment, the recovered binding molecule comprises a Fv domain of a first antibody which is capable of binding to influenza A virus haemagglutinin (HA) and neutralize at least one subtype of group 1 and at least one subtype of group 2 of influenza A virus and domain Fv of second antibody, which is able to bind to HA influenza B virus and neutralize influenza virus B of two phylogenetically different lines.
EFFECT: invention extends the range of products associated with influenza A and influenza B viruses.
12 cl, 6 dwg, 12 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
HUMAN IL-13 ANTIBODY MOLECULES | 2004 |
|
RU2387667C2 |
ANTIBODIES AGAINST HEPATITIS B VIRUS AND THEIR USE | 2020 |
|
RU2803082C2 |
PARTNERS OF SPECIFIC BINDING WITH NGF | 2006 |
|
RU2406728C2 |
ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2649368C2 |
ANTIBODIES TO ICOS | 2016 |
|
RU2742241C2 |
ANTIBODY AGAINST IL-4R AND APPLICATION THEREOF | 2018 |
|
RU2758091C1 |
ANTI-IL-1R1 BINDING MEMBERS | 2009 |
|
RU2555532C2 |
ANTIBODIES SPECIFIC TO BTN2 AND THEIR APPLICATIONS | 2018 |
|
RU2794996C2 |
DOSAGE REGIMENS FOR ANTIBODIES AGAINST TIM-3 AND THEIR USE | 2018 |
|
RU2804775C2 |
ANTIBODY MOLECULES AGAINST APRIL AND APPLICATIONS THEREOF | 2016 |
|
RU2793755C2 |
Authors
Dates
2020-05-21—Published
2016-05-31—Filed